Debt-to-equity of ACRO BIOMEDICAL CO., LTD. from 31 Dec 2016 to 31 Dec 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
ACRO BIOMEDICAL CO., LTD. quarterly Debt-to-equity in % history and change rate from 31 Dec 2016 to 31 Dec 2024.
  • ACRO BIOMEDICAL CO., LTD. Debt-to-equity for the quarter ending 31 Dec 2024 was -115%.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

ACRO BIOMEDICAL CO., LTD. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q4 2024 -115% 31 Dec 2024
Q3 2024 -118% 30 Sep 2024
Q2 2024 -117% 30 Jun 2024
Q4 2022 24% +2.1% +9.5% 31 Dec 2022
Q3 2022 19% -10% -35% 30 Sep 2022
Q2 2022 15% -20% -57% 30 Jun 2022
Q1 2022 13% -23% -64% 31 Mar 2022
Q4 2021 22% -5.9% -21% 31 Dec 2021
Q3 2021 29% +7.9% +37% 30 Sep 2021
Q2 2021 34% +15% +78% 30 Jun 2021
Q1 2021 36% +19% +111% 31 Mar 2021
Q4 2020 28% +11% +68% 31 Dec 2020
Q3 2020 22% +7.2% +50% 30 Sep 2020
Q2 2020 19% +5.1% +36% 30 Jun 2020
Q1 2020 17% +0.06% +0.38% 31 Mar 2020
Q4 2019 17% -3.7% -18% 31 Dec 2019
Q3 2019 14% -12% -45% 30 Sep 2019
Q2 2019 14% -11% -44% 30 Jun 2019
Q1 2019 17% -8.6% -33% 31 Mar 2019
Q4 2018 20% -4.1% -17% 31 Dec 2018
Q3 2018 26% +1.2% +4.9% 30 Sep 2018
Q2 2018 26% +137% 30 Jun 2018
Q1 2018 26% +141% 31 Mar 2018
Q4 2017 24% +176% 31 Dec 2017
Q3 2017 25% 30 Sep 2017
Q2 2017 -112% 30 Jun 2017
Q1 2017 -115% 31 Mar 2017
Q4 2016 -151% 31 Dec 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.